Bandingkan Harga & Kinerja Bundamedik Tbk (BMHS) vs Catur Sentosa Adiprana Tbk. (CSAP)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bundamedik Tbk dan Catur Sentosa Adiprana Tbk.: Bundamedik Tbk diperdagangkan di Rp176 (kapitalisasi pasar 1,51 T, volume 24 jam 536,7 rb), sedangkan Catur Sentosa Adiprana Tbk. diperdagangkan di Rp284 (kapitalisasi pasar 1,61 T, volume 24 jam 23 rb). Perbedaan utamanya: Bundamedik Tbk dan Catur Sentosa Adiprana Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan Bundamedik Tbk lebih aktif diperdagangkan (536,7 rb vs 23 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BMHS | CSAP | |
|---|---|---|
Kapitalisasi Pasar | 1,51 T | 1,61 T |
Volume | 536,7 rb | 23 rb |
Lot | 5,37 rb | 230 |
Perputaran | 93,41 jt | 6,57 jt |
Harga Rata-rata | 174,05 | 285,67 |
Nilai Transaksi | 93,41 jt | 6,57 jt |
Harga Ekuilibrium Indikatif | 176 | 282 |
Volume Ekuilibrium Indikatif | 100 | 3 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Selengkapnya di halaman BMHS →Tentang Catur Sentosa Adiprana Tbk.
Catur Sentosa Adiprana Tbk (the company) was established on 31 Dec 1983 based on Notaries Deed No. 93 and the deed of establishment was approved by the the Ministry of Justice dated Sep 18, 1983. Based on the Company’s stockholders’ circular resolution dated June 6, 2007, the stockholders approved the change in the legal status of the Company from a Limited Liability Company “Perseroan Terbatas” with Foreign Capital Investments facility to a Limited Liability Company “Perseroan Terbatas” with Non-Foreign Capital Investments facility/Domestic Capital Investments, including the revocation and/or cancellation of every existing agreement of the Company related to Foreign Capital Investments.
Selengkapnya di halaman CSAP →
